In March, the White House launched its “test-to-treat” initiative, a program allowing high-risk patients with COVID-19 symptoms to get tested at pharmacies and receive free antiviral pills on the spot. But the rollout has not been going as smoothly as many hoped.
Read the full post on Becker's Hospital Review - Healthcare News
